Nanofiber-based delivery of therapeutic peptides to the brain

ACS Nano

Volumn 7, Issue 2, 2013, Pages 1016-1026

  Mazza, Mariarosa ^a   Notman, Rebecca ^b   Anwar, Jamshed ^c   Rodger, Alison ^b   Hicks, Matthew ^b   Parkinson, Gary ^a   McCarthy, Dave ^a   Daviter, Tina ^d   Moger, Julian ^e   Garrett, Natalie ^e   Mead, Tania ^f   Briggs, Michael ^f   Schätzlein, Andreas G ^a   Uchegbu, Ijeoma F ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF EXETER   (United Kingdom)

^f GLAXOSMITHKLINE   (United Kingdom)

Author keywords

blood brain barrier; dalargin; nanofibers; palmitoyl dalargin; peptide brain delivery; self assembly

Indexed keywords

ACTIVE PEPTIDES; AMPHIPHILIC PEPTIDES; AMPHIPHILICS; BLOOD-BRAIN BARRIER; BRAIN DELIVERY; CENTRAL NERVOUS SYSTEMS; DALARGIN; SELF-ASSEMBLE; THERAPEUTIC PEPTIDES; THERAPEUTIC PEPTIDES AND PROTEINS;

BLOOD; NANOFIBERS; SELF ASSEMBLY;

PEPTIDES;

DRUG CARRIER; DRUG DERIVATIVE; ENKEPHALIN LEU, ALA(2) ARG(6); ENKEPHALIN-LEU, ALA(2)-ARG(6)-; ENKEPHALIN[2 ALANINE 5 LEUCINE]; NANOFIBER; PEPTIDE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; NANOMEDICINE; PROTEIN CONFORMATION;

BLOOD-BRAIN BARRIER; BRAIN; DRUG CARRIERS; ENKEPHALIN, LEUCINE-2-ALANINE; MODELS, MOLECULAR; NANOFIBERS; NANOMEDICINE; PEPTIDES; PROTEIN CONFORMATION;

EID: 84874406744     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn305193d     Document Type: Article

References (56)

1. Lalatsa, A.; Schätzlein, A. G.; Uchegbu, I. F., Drug Delivery across the Blood Brain Barrier. In Comprehensive Biotechnology 2nd ed., MurrayMoo-Young, M.; Butler, M.; Webb, C.; Moreira, A.; Grodzinski, B.; Cui, Z., Eds. Elsevier: Amsterdam, 2011; pp 657-668.
2. Carter, M. D.; Simms, G. A.; Weaver, D. F. The Development of New Therapeutics for Alzheimer's Disease Clin. Pharmacol. Ther. 2010, 88, 475-486
3. Brasnjevic, I.; Steinbusch, H. W.; Schmitz, C.; Martinez-Martinez, P. Delivery of Peptide and Protein Drugs over the Blood-Brain Barrier Prog. Neurobiol. 2009, 87, 212-251
4. Hughes, J.; Smith, T. W.; Kosterlitz, H. W.; Fothergill, L. A.; Morgan, B. A.; Morris, H. R. Identification of Two Related Pentapeptides from the Brain with Potent Opiate Agonist Activity Nature 1975, 258, 577-580
5. Mathers, C. D.; Loncar, D. Projection of Global Mortality and Burden of Disease from 2002 to 2030 Plos Med. 2006, 3, 2011-2030
6. Pardridge, W. M. Drug Targeting to the Brain Pharm. Res. 2007, 24, 1733-1744
7. Beduneau, A.; Hindre, F.; Clavreul, A.; Leroux, J. C.; Saulnier, P.; Benoit, J. P. Brain Targeting Using Novel Lipid Nanovectors J. Controlled Release 2008, 126, 44-49
8. Pardridge, W. M.; Boado, R. J. Delivery of Pharmaceutical Agents via the Human Insulin Receptor; U.S. Patent 7,388,079, 2008.
9. Regina, A.; Demeule, M.; Che, C.; Lavallee, I.; Poirier, J.; Gabathuler, R.; Beliveau, R.; Castaigne, J. P. Antitumour Activity of ANG1005, a Conjugate between Paclitaxel and the New Brain Delivery Vector Angiopep-2 Br. J. Pharmacol. 2008, 155, 185-197
10. Mazza, M.; Uchegbu, I. F.; Schatzlein, A. G. Cancer and the Blood-Brain Barrier: 'Trojan Horses' for Courses? Br. J. Pharmacol. 2008, 155, 149-151
11. Bihorel, S.; Camenisch, G.; Lemaire, M.; Scherrmann, J. M. Modulation of the Brain Distribution of Imatinib and Its Metabolites in Mice By Valspodar, Zosuquidar and Elacridar Pharm. Res. 2007, 24, 1720-1728
12. Deeken, J. F.; Loscher, W. The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses Clin. Cancer Res. 2007, 13, 1663-1674
13. Kreuter, J.; Ramge, P.; Petrov, V.; Hamm, S.; Gelperina, S. E.; Engelhardt, B.; Alyautdin, R.; von Briesen, H.; Begley, D. J. Direct Evidence that Polysorbate-80-Coated Poly(butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles Pharm. Res. 2003, 20, 409-416
14. Adenot, M.; Merida, P.; Lahana, R. Applications of a Blood-Brain Barrier Technology Platform To Predict CNS Penetration of Various Chemotherapeutic Agents Chemotherapy 2007, 53, 73-76
15. Fleming, A. B.; Saltzman, W. M. Pharmacokinetics of the Carmustine Implant Clin. Pharmacokinet. 2002, 41, 403-419
16. Debinski, W.; Tatter, S. B. Convection-Enhanced Delivery To Achieve Widespread Distribution of Viral Vectors: Predicting Clinical Implementation Curr. Opin. Mol. Ther. 2010, 12, 647-653
17. Takeda, T.; Saitoh, M.; Takeda, S. Solitary Cystic Brain Metastasis of Small-Cell Lung Carcinoma Controlled by a Stereotactically Inserted Ommaya Reservoir Am. J. Med. Sci. 2009, 337, 215-217
18. Jolliet-Riant, P.; Tillement, J. P. Drug Transfer Across the Blood-Brain Barrier and Improvement of Brain Delivery Fundam. Clin. Pharmacol. 1999, 13, 16-26
19. Hansen, D. W.; Stapelfeld, A.; Savage, M. A.; Reichman, M.; Hammond, D. L.; Haaseth, R. C.; Mosberg, H. I. Systemic Analgesic Activity and Delta-Opioid Selectivity in 2,6-Dimethyl-Tyr1, d -Pen2, d -Pen5 Enkephalin J. Med. Chem. 1992, 35, 684-687
20. Weber, S. J.; Greene, D. L.; Sharma, S. D.; Yamamura, H. I.; Kramer, T. H.; Burks, T. F.; Hruby, V. J.; Hersh, L. B.; Davis, T. P. Distribution and Analgesia of H-3 D-Pen2,D-Pen5 Enkephalin and 2-Halogenated Analogs after Intravenous Administration J. Pharmacol. Exp. Ther. 1991, 259, 1109-1117
21. Bodor, N.; Prokai, L.; Wu, W. M.; Farag, H.; Jonalagadda, S.; Kawamura, M.; Simpkins, J. A Strategy for Delivering Peptides into the Central Nervous System by Sequential Metabolism Science 1992, 257, 1698-1700
22. Batrakova, E. V.; Vinogradov, S. V.; Robinson, S. M.; Niehoff, M. L.; Banks, W. A.; Kabanov, A. V. Polypeptide Point Modifications with Fatty Acid and Amphiphilic Block Copolymers for Enhanced Brain Delivery Bioconjugate Chem. 2005, 16, 793-802
23. Egleton, R. D.; Abbruscato, T. J.; Thomas, S. A.; Davis, T. P. Transport of Opioid Peptides into the Central Nervous System J. Pharm. Sci. 1998, 87, 1433-1439
24. Tysseling-Mattiace, V. M.; Sahni, V.; Niece, K. L.; Birch, D.; Czeisler, C.; Fehlings, M. G.; Stupp, S. I.; Kessler, J. A. Self-Assembling Nanofibers Inhibit Glial Scar Formation and Promote Axon Elongation after Spinal Cord Injury J. Neurosci. 2008, 28, 3814-3823
25. Zhou, M.; Smith, A. M.; Das, A. K.; Hodson, N. W.; Collins, R. F.; Ulijn, R. V.; Gough, J. E. Self-Assembled Peptide-Based Hydrogels as Scaffolds for Anchorage-Dependent Cells Biomaterials 2009, 30, 2523-2530
26. Standley, S. M.; Toft, D. J.; Cheng, H.; Soukasene, S.; Chen, J.; Raja, S. M.; Band, V.; Band, H.; Cryns, V. L.; Stupp, S. I. Induction of Cancer Cell Death by Self-Assembling Nanostructures Incorporating a Cytotoxic Peptide Cancer Res. 2010, 70, 3020-3026
27. 2) (2) Analogs of Enkephalins and their Selectivity for Mu-Opioid Receptors Gen. Pharmacol. 1995, 26, 799-808
28. Lalatsa, A.; Lee, V.; Malkinson, J. P.; Zloh, M.; Schatzlein, A. G.; Uchegbu, I. F. A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine(5)-Enkephalin, to the Brain Mol. Pharmaceutics 2012, 9, 1665-1680
29. Andersen, C. B.; Hicks, M. R.; Vetri, V.; Vandahl, B.; Rahbek-Nielsen, H.; Thogersen, H.; Thogersen, I. B.; Enghild, J. J.; Serpell, L. C.; Rischel, C.; Otzen, D. E. Glucagon Fibril Polymorphism Reflects Differences in Protofilament Backbone Structure J. Mol. Biol. 2010, 397, 932-946
30. Krebs, M. R.; Macphee, C. E.; Miller, A. F.; Dunlop, I. E.; Dobson, C. M.; Donald, A. M. The Formation of Spherulites by Amyloid Fibrils of Bovine Insulin Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 14420-14424
31. Ewles, M.; Goodwin, L. Bioanalytical Approaches to Analyzing Peptides and Proteins By LC-MS/MS Bioanalysis 2011, 3, 1379-1397
32. Rauh, M. LC-MS/MS For Protein and Peptide Quantification in Clinical Chemistry J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2012, 883, 59-67
33. Kalenikova, E. I.; Dmitrieva, O. F.; Korobov, N. V.; Zhukovskii, S. V.; Tishchenko, V. A. Pharmacokinetics of Dalargin Vopr. Med. Khim. 1988, 34, 75-83
34. van Rooy, I.; Cakir-Tascioglu, S.; Hennink, W. E.; Storm, G.; Schiffelers, R. M.; Mastrobattista, E. In Vivo Methods To Study Uptake of Nanoparticles into the Brain Pharm. Res. 2011, 28, 456-471
35. Min, W.; Freudiger, C. W.; Lu, S. J.; Xie, X. S. Coherent Nonlinear Optical Imaging: Beyond Fluorescence Microscopy Annu. Rev. Phys. Chem. 2011, 62, 507-530
36. Garrett, N. L.; Lalatsa, A.; Begley, D.; Mihoreanu, L.; Uchegbu, I. F.; Schätzlein, A. G.; Moger, J. Label-Free Imaging of Polymeric Nanomedicines Using Coherent Anti-Stokes Raman Scattering Microscopy J. Raman Spectrosc. 2012, 43, 681-688
37. Garrett, N. L.; Lalatsa, A.; Uchegbu, I.; Schatzlein, A.; Moger, J. Exploring Uptake Mechanisms of Oral Nanomedicines Using Multimodal Nonlinear Optical Microscopy J. Biophotonics 2012, 5, 458-468
38. Lalatsa, A.; Garrett, N.; Moger, J.; Schatzlein, A. G.; Davis, C.; Uchegbu, I. F. Delivery of Peptides to the Blood and Brain after Oral Uptake of Quaternary Ammonium Palmitoyl Glycol Chitosan Nanoparticles Mol. Pharmaceutics 2012, 9, 1764-1774
39. Beniash, E.; Hartgerink, J. D.; Storrie, H.; Stendahl, J. C.; Stupp, S. I. Self-Assembling Peptide Amphiphile Nanofiber Matrices for Cell Entrapment Acta Biomater. 2005, 1, 387-397
40. Wagner, S.; Zensi, A.; Wien, S. L.; Tschickardt, S. E.; Maier, W.; Vogel, T.; Worek, F.; Pietrzik, C. U.; Kreuter, J.; von Briesen, H. Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model PLoS One 2012, 7, e32568
41. Andrieux, K.; Couvreur, P. Polyalkylcyanoacrylate Nanoparticles for Delivery of Drugs Across the Blood-Brain Barrier Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009, 1, 463-474
42. Knipe, J. O.; Mosure, K. W. Nonclinical Pharmacokinetics of BMS-292655, a Water-Soluble Prodrug of the Antifungal Ravuconazole Biopharm. Drug Dispos. 2008, 29, 270-279
43. Sharkey, E. M.; O'Neill, H. B.; Kavarana, M. J.; Wang, H. B.; Creighton, D. J.; Sentz, D. L.; Eiseman, J. L. Pharmacokinetics and Antitumor Properties in Tumor-Bearing Mice of an Enediol Analogue Inhibitor of Glyoxalase I Cancer Chemother. Pharmacol. 2000, 46, 156-166
44. Cassel, J. A.; Daubert, J. D.; DeHaven, R. N. H-3 Alvimopan Binding to the Mu Opioid Receptor: Comparative Binding Kinetics of Opioid Antagonists Eur. J. Pharmacol. 2005, 520, 29-36
45. Maslov, L. N.; Fedorova, N. A.; Dudko, V. A.; Karpov, R. S. Effect of Peripheral Opiate Receptor Agonist Dalargin on Exercise Tolerance in Patients with Coronary and Peripheral Arteries Atherosclerosis Fiziol. Chel. 2002, 28, 81-87
46. Hamley, I. W.; Castelletto, V.; Moulton, C. M.; Rodriguez-Perez, J.; Squires, A. M.; Eralp, T.; Held, G.; Hicks, M. R.; Rodger, A. Alignment of a Model Amyloid Peptide Fragment in Bulk and at a Solid Surface J. Phys. Chem. B 2010, 114, 8244-8254
47. Maurer-Stroh Sebastian, D. M.; Kuemmerer, N.; Lopez de la Paz, M.; Martins, I. C.; Reumers, J.; Morris, K. L.; Copland, A.; Serpell, L.; Serrano, L.; Schymkovitz, J. W. H.; Rousseau, F. Exploring the Sequence Determinants of Amyloid Structure Using Position-Specific Scoring Matrices Nat. Methods 2010, 7, 237-242
48. Pashuck, E. T.; Stupp, S. I. Direct Observation of Morphological Transformation from Twisted Ribbons into Helical Ribbons J. Am. Chem. Soc. 2010, 132, 8819-8821
49. Hartgerink, J. D.; Beniash, E.; Stupp, S. I. Self-Assembly and Mineralization of Peptide-Amphiphile Nanofibers Science 2001, 294, 1684-1688
50. Lee, O. S.; Stupp, S. I.; Schatz, G. C. Atomistic Molecular Dynamics Simulations of Peptide Amphiphile Self-Assembly into Cylindrical Nanofibers J. Am. Chem. Soc. 2011, 133, 3677-3683
51. Wong, P. E.; Tetley, L.; Dufes, C.; Chooi, K. W.; Bolton, K.; Schätzlein, A. G.; Uchegbu, I. F. Polyamine Aza-Cyclic Compounds Demonstrate Anti-Proliferative Activity in Vitro but Fail To Control Tumour Growth in Vivo J. Pharm. Sci. 2010, 99, 4642-4657
52. Siew, A.; Le, H.; Thiovolet, M.; Gellert, P.; Schatzlein, A.; Uchegbu, I. Enhanced Oral Absorption of Hydrophobic and Hydrophilic Drugs Using Quaternary Ammonium Palmitoyl Glycol Chitosan Nanoparticles Mol. Pharmaceutics 2012, 9, 14-28
53. Hess, B.; Kutzner, C.; van der Spoel, D.; Lindahl, E. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation J. Chem. Theory Comput. 2008, 4, 435-447
54. Marrink, S. J.; Risselada, H. J.; Yefimov, S.; Tieleman, D. P.; De Vries, A. H. The MARTINI Force Field: Coarse Grained Model for Biomolecular Simulations J. Phys. Chem. B 2007, 111, 7812-7824
55. Monticelli, L.; Kandasamy, S. K.; Periole, X.; Larson, R. G.; Tieleman, D. P.; Marrink, S. J. The MARTINI Coarse-Grained Force Field: Extension to Proteins J. Chem. Theory Comput. 2008, 4, 819-834
56. Moger, J.; Garrett, N. L.; Begley, D.; Mihoreanu, L.; Lalatsa, A.; Lozano, M.; Mazza, M.; Schatzlein, A.; Uchegbu, I. F. Imaging Cortical Vasculature with Stimulated Raman Scattering and Two Photon Photothermal Lensing Microscopy J. Raman Spectrosc. 2012, 43, 668-674